DOCSLIB.ORG

Processing and Transport of Retinoids by the Retinal Pigment Epithelium

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Processing and Transport of Retinoids by the Retinal Pigment Epithelium Eye (1990) 4, 326-332 Processing and Transport of Retinoids by the Retinal Pigment Epithelium DE AN BOK Los Angeles Summary Recent developments regarding our understanding of retinoid processing and trans­ port during the visual cycle and related events are reviewed. Retinoids are bound and protected by a cohort of retinoid binding proteins, each of whiCh is unique. The production of retinol (Vitamin A) derivatives is accomplished by a group of mem­ brane-bound enzymes, some of which appear to be coupled in their actions. Historical Perspectives on a series of biochemical reactions involving The photopigments of all organisms studied the coordinated activity of the retinal pigment to date consist of a chromophore derived from epithelium (RPE) and the photoreceptors.3 Vitamin A (Retinol)! covalently bound to a These events begin with the photobleaching protein by a protonated aldimine bond of rhodopsin to form opsin and all-trans·ret· (Schiff's base).2 The chromophore or pros­ inal, the production of various retinol deriva­ thetic group is, in all cases, retinaldehyde (ret­ tives, the regeneration of ll-cis-retinal and inal) the oxidised form of retinol. Retinol and ultimately, the regeneration of the photopig­ its derivatives are collectively referred to as ment itself. This complex series of interac­ retinoids and the proteins that covalently bind tions is known as the visual cycle. In retinal are called opsins. Both the retinoids Dowling's original observations, light was and the opsins are hydrophobic molecules, found to cause a cis to trans isomerisation of retinol being a fat-soluble vitamin, and the opsin-bound retinal following which retinal opsins belonging to a class of membrane com­ dissociated from the protein and was reduced ponents collectively known as intrinsic pro­ to form all-trans-retinol. The all-trans-retinol teins. These are amphipathic molecules was then observed to diffuse out of the photo· (meaning to tolerate both) whose fat-loving receptors, into the subretinal (retinal ventri· moieties are dissolved in the lipid bilayer of cular) space and into the retinal pigment cell membranes and whose water-loving epithelium (RPE) where it was converted to domains are exposed to the cytoplasm or cell retinyl esters. Subsequently, in the dark, ret· exterior. inyl esters were hydrolysed and the photo­ The photopigments of the vertebrate retina pigments were regenerated. utilise either the ll-cis-retinal stereoisomer or Initial studies of the visual cycle were not the ll-cis-dehydroretinal form. Humans util­ able to determine precisely the cellular sites in ise 11-cis-retinal exclusively as far as we know. which all of the requisite steps take place, In 1960, Dowling published his classic work although it was assumed that many occurred From: Department of Anatomy and Cell Biology and the Jules Stein Eye Institute, C�nter for the Health Sciences, University of California, Los Angeles, CA 90024. Some of the work cited in this publication was supported by USPHS grants EYOO444 and EYOO331 and by a Center Grant from Retinitis Pigmentosa Fighting Blindness Inc. DB is Dolly Green Professor of Ophthalmology. Correspondence to: Dean Bok, PhD, Jules Stein Eye Institute, University of California, Los Angeles,CA 90024. PROCESSING AND TRANSPORT OF RETINOIDS BY THE RETINAL PIGMENT EPITHELIUM 327 in the RPE. It was clear that all-trans-retinol protection of retinoids because of their was formed in the photoreceptors and that extreme hydrophobicity and susceptibility to retinyl esters were formed in the RPE. oxidation. The solubility of retinol in water is Beyond that, specific details were lacking. about one nanomolar, yet its concentration in Clearly there had to be a site of reisomer­ the blood is approximately one micromolar, a isation of the retinoids at some point and for one thousand-fold difference. In 1976 Heller the oxidation of retinol to retinal. In spite of and Bok showed that RBP delivers all-trans­ an early, unconfirmed report that isomerisa­ retinol to the RPE by interacting with mem­ tion was an event that occurs in the RPE,4 brane receptors on its basolateral plasma very little progress was made toward a further membrane (the side facing Bruch's mem­ understanding of the multiple steps in the brane).9 It arrives at this location by penetrat­ visual cycle for many years, although Krinsky ing the endothelium of the choriocapillaris demonstrated the presence of a retinyl ester through its fenestrations. Once RBP delivers synthetase in the RPE5 and Lion et al. were its cargo of retinol to the RPE, it loses its high able to demonstrate that mammalian RPE, affinity for TTR and the two diffuse back into but not neurosensory retina, contains a the choriocapillaris. At the time that these stereospecific oxidoreductase capable of con­ phenomena were discovered, Chader and verting ll-cis-retinol to ll-cis-retinal.6 Pep­ associates were discovering other, intracellu­ perberg and Masland showed that lar retinoid binding proteins in the retinaiO ll-cis-retinal oxidation could take place in the and shortly thereafter, Saari and coworkers outer segments of amphibians.7 began the purification and characterisation of One of the major reasons why events in the these proteins.ll,12 They and others, including visual cycle were so difficult to study was the our laboratory, began the systematic local­ extreme hydrophobicity of the retinoids and isation by immunocytochemistry of each of the difficultythat this property causes in aque­ these binding proteins within retinal cell ous systems. Furthermore, the retinoids are populations. A protein that binds all-trans­ highly labile to oxidation and artifactual iso­ retinol intracellularly, named cellular retinol merisation and are difficult to separate. It was binding protein (CRBP) by Bashor et al. in not until the advent of high performance their study of non-ocular tissues,13 was local­ liquid chromatography that these compounds ised to RPE and Muller cells.14 Another bind­ could be resolved rapidly from complex mix­ ing protein, unique to the retina, was tures in tissue homogenates. The lack of a discovered by Futterman et al. to bind the IS wide variety of detergents for the solubilisa­ ll-cis stereoisomers of retinol and retinal. tion of membrane-bound enzymes was an Since this protein was found to bind ll-cis­ important impediment to our understanding retinal initially, it was named cellular retinal of visual cycle enzymes. Lacking also was an binding protein (CRalBP). Like CRBP, it was appreciation of the important role for retinoid found to exist in RPE and Muller cells. binding proteins in the solubilisation of ret­ Finally, Adler et al.16 discovered another inoids. The door to the world of these binding large, extracellular protein in the subretinal proteins was opened in the late 1960s with the space which was shown to have retinoid bind­ discovery of the first retinoid binding protein. ing properties by the laboratories of Chaderl7 and Bridges. 18 This is a glycoprotein with low Retinoid Binding Proteins and Their Role in specificity for individual retinoids. It is syn­ Retinoid Protection and Transport thesised and secreted by the photoreceptorsl9 Kanai et al. reported the discovery of plasma and, by virtue of its location, is called inter­ retinol binding protein (RBP) in 1968.8 This photoreceptor or interstitial retinoid binding protein is secreted by the liver as a complex protein (lRBP). All of these binding proteins with a larger protein named transthyretin have been sequenced by molecular cloning (TTR) because of its binding of thyroxin and methods and some by conventional protein its indirect binding of retinol through its chemistry as well. CRBP belongs to a gene association with RBP. Retinoid binding pro­ family of proteins that bind retinal, retinoic teins are required for the solubilisation and acid and fatty acids (the latter are called fatty 328 DEAN BOK acid binding proteins).20 CRalBP has a unique gave negative results. Likewise, since enzyme amino acid sequence and is found in no tissues activity could not be studied there was con­ outside the eye.21 IRBP is found in small siderable uncertainty as to the energy require­ quantities in the brain and is abundant in the ments and natural substrate for the enzyme. pineal gland, a structure with primitive photo­ These problems were recently resolved in a receptive function. 19 Interestingly, it has some series of publications from Robert Rando's sequence homology with a cellular retinal laboratory. First, it was shown by Bernstein binding protein in cephalopods.22 and Rand024 that isomerisation occurs at the The discovery of retinoid binding proteins alcohol-oxidation state. Subsequently, in an and their localisations to specific cell types interesting series of experiments, Bernstein et within the retina have helped significantly in al. discovered that the 30-year quest for iso­ our understanding of the division of labour merising activity had been thwarted by the that exists within the retina with respect to ret­ organic solvents in which the substrates had inoids. Much remains to be learned, however been delivered to tissue homogenates.25 about the function of these proteins. Aside When the all-trans-retinol was solubilised by from serving as protective depots for ret­ bovine serum albumin rather than ethanol, inoids, more sophisticated functions remain the traditional solvent, isomerising activity to be elucidated. As yet, with the exception of was readily detected and virtually all of this RBP, none have been implicated in intra or activity was found in the microsomal fraction extracellular receptor-mediated processes, of the RPE-choroid complex. Virtually none although Saari and Bredberg have shown that was found in the neurosensory retina. CRalBP can serve in vitro as a substrate car­ Improved cell culture techniques have also rier for the oxidation of 11-cis-retinol to 11- supported the in vitro evidence that retinoid cis-retinal.23 More will be said later about isomerase is an RPE enzyme.
Load more

Recommended publications
  • Dominant Retinas: a Novel Pathway for Visual- Pigment Regeneration in Daylight
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Neuron, Vol. 36, 69–80, September 26, 2002, Copyright 2002 by Cell Press Isomerization and Oxidation of Vitamin A in Cone- Dominant Retinas: A Novel Pathway for Visual- Pigment Regeneration in Daylight Nathan L. Mata,1 Roxana A. Radu,1 cis-retinaldehyde through a multistep pathway called Richard S. Clemmons,3 and Gabriel H. Travis1,2,4 the visual cycle (Figure 1B). Most of what is known about 1Jules Stein Eye Institute the visual cycle has come from the study of rod-domi- 2 Department of Biological Chemistry nant species such as cattle and rodents. UCLA School of Medicine Several lines of evidence suggest that rod and cone Los Angeles, California 90095 photopigments regenerate by different mechanisms. In 3 Center for Basic Neuroscience frog retinas separated from the retinal pigment epithe- UT Southwestern Medical Center lium (RPE), cone opsin, but not rhodopsin, regenerates Dallas, Texas 75235 spontaneously (Goldstein and Wolf, 1973; Hood and Hock, 1973). After bleaching, isolated salamander cones, but not rods, recover sensitivity with addition of Summary 11-cis-retinol (Jones et al., 1989). Cultured Mu¨ ller cells isomerize all-trans-retinol to 11-cis-retinol, which they The first step toward light perception is 11-cis to all- secrete into the medium (Das et al., 1992). Mu¨ ller cells, trans photoisomerization of the retinaldehyde chro- in addition to RPE cells, contain cellular retinaldehyde mophore in a rod or cone opsin-pigment molecule. binding protein (CRALBP), which specifically binds 11- Light sensitivity of the opsin pigment is restored cis-retinoids (Bunt-Milam and Saari, 1983; Saari and through a multistep pathway called the visual cycle, Bredberg, 1987).
    [Show full text]
  • Retinoid Isomerase Inhibitors Impair but Do Not Block Mammalian Cone Photoreceptor Function
    Published Online: 2 March, 2018 | Supp Info: http://doi.org/10.1085/jgp.201711815 Downloaded from jgp.rupress.org on April 2, 2018 RESEARCH ARTICLE Retinoid isomerase inhibitors impair but do not block mammalian cone photoreceptor function Philip D. Kiser1,2, Jianye Zhang2, Aditya Sharma3, Juan M. Angueyra4, Alexander V. Kolesnikov3, Mohsen Badiee5, Gregory P. Tochtrop5, Junzo Kinoshita6, Neal S. Peachey1,6,7, Wei Li4, Vladimir J. Kefalov3, and Krzysztof Palczewski2 Visual function in vertebrates critically depends on the continuous regeneration of visual pigments in rod and cone photoreceptors. RPE65 is a well-established retinoid isomerase in the pigment epithelium that regenerates rhodopsin during the rod visual cycle; however, its contribution to the regeneration of cone pigments remains obscure. In this study, we use potent and selective RPE65 inhibitors in rod- and cone-dominant animal models to discern the role of this enzyme in cone-mediated vision. We confirm that retinylamine and emixustat-family compounds selectively inhibit RPE65 over DES1, the putative retinoid isomerase of the intraretinal visual cycle. In vivo and ex vivo electroretinography experiments in Gnat1−/− mice demonstrate that acute administration of RPE65 inhibitors after a bleach suppresses the late, slow phase of cone dark adaptation without affecting the initial rapid portion, which reflects intraretinal visual cycle function. Acute administration of these compounds does not affect the light sensitivity of cone photoreceptors in mice during extended exposure to background light, but does slow all phases of subsequent dark recovery. We also show that cone function is only partially suppressed in cone-dominant ground squirrels and wild-type mice by multiday administration of an RPE65 inhibitor despite profound blockade of RPE65 activity.
    [Show full text]
  • Meet Lycopene Prostate Cancer Is One of the Leading Causes of Cancer Death Among Men in the United States
    UCLA Nutrition Noteworthy Title Lycopene and Mr. Prostate: Best Friends Forever Permalink https://escholarship.org/uc/item/5ks510rw Journal Nutrition Noteworthy, 5(1) Author Simzar, Soheil Publication Date 2002 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Meet Lycopene Prostate cancer is one of the leading causes of cancer death among men in the United States. Dietary factors are considered an important risk factor for the development of prostate cancer in addition to age, genetic predisposition, environmental factors, and other lifestyle factors such as smoking. Recent studies have indicated that there is a direct correlation between the occurrence of prostate cancer and the consumption of tomatoes and tomato-based products. Lycopene, one of over 600 carotenoids, is one of the main carotenoids found in human plasma and it is responsible for the red pigment found in tomatoes and other foods such as watermelons and red grapefruits. It has been shown to be a very potent antioxidant, with oxygen-quenching ability greater than any other carotenoid. Recent research has indicated that its antioxidant effects help lower the risk of heart disease, atherosclerosis, and different types of cancer-especially prostate cancer. Lycopene's Characteristics Lycopene is on of approximately 600 known carotenoids. Carotenoids are red, yellow, and orange pigments which are widely distributed in nature and are especially abundant in yellow- orange fruits and vegetables and dark green, leafy vegetables. They absorb light in the 400- 500nm region which gives them a red/yellow color. Only green plants and certain microorganisms such as fungi and algae can synthesize these pigments.
    [Show full text]
  • Metabolism in the Aging Retina and Retinal Degeneration
    Hindawi Oxidative Medicine and Cellular Longevity Volume 2020, Article ID 2692794, 12 pages https://doi.org/10.1155/2020/2692794 Review Article Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration Ravirajsinh N. Jadeja ,1 Menaka C. Thounaojam ,2,3 Manuela Bartoli ,2,3 and Pamela M. Martin 1,2,3 1Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA 2Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA 3James and Jean Culver Vision Discovery Institute and Medical College of Georgia at Augusta University, Augusta, GA, USA Correspondence should be addressed to Ravirajsinh N. Jadeja; [email protected] and Pamela M. Martin; [email protected] Received 8 February 2020; Accepted 17 April 2020; Published 11 May 2020 Academic Editor: Ryoji Nagai Copyright © 2020 Ravirajsinh N. Jadeja et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Nicotinamide adenine dinucleotide (NAD+) plays an important role in various key biological processes including energy metabolism, DNA repair, and gene expression. Accumulating clinical and experimental evidence highlights an age-dependent decline in NAD+ levels and its association with the development and progression of several age-related diseases. This supports the establishment of NAD+ as a critical regulator of aging and longevity and, relatedly, a promising therapeutic target to counter adverse events associated with the normal process of aging and/or the development and progression of age-related disease. Relative to the above, the metabolism of NAD+ has been the subject of numerous investigations in various cells, tissues, and organ systems; however, interestingly, studies of NAD+ metabolism in the retina and its relevance to the regulation of visual health and function are comparatively few.
    [Show full text]
  • Serum Retinal and Retinoic Acid Predict the Development of Type 2 Diabetes Mellitus in Korean Subjects with Impaired Fasting Glucose from the KCPS-II Cohort
    H OH metabolites OH Article Serum Retinal and Retinoic Acid Predict the Development of Type 2 Diabetes Mellitus in Korean Subjects with Impaired Fasting Glucose from the KCPS-II Cohort Youngmin Han 1 , Yeunsoo Yang 2 , Minjoo Kim 3 , Sun Ha Jee 2, Hye Jin Yoo 4,* and Jong Ho Lee 1,4,* 1 National Leading Research Laboratory of Clinical Nutrigenetics/Nutrigenomics, Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul 03722, Korea; [email protected] 2 Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul 03722, Korea; [email protected] (Y.Y.); [email protected] (S.H.J.) 3 Department of Food and Nutrition, College of Life Science and Nano Technology, Hannam University, Daejeon 34430, Korea; [email protected] 4 Research Center for Silver Science, Institute of Symbiotic Life-TECH, Yonsei University, Seoul 03722, Korea * Correspondence: [email protected] (H.J.Y.); [email protected] (J.H.L.); Tel.: +82-2-364-9605 (H.J.Y.); +82-2-2123-3122 (J.H.L.); Fax: +82-2-364-9605 (H.J.Y. & J.H.L.) Abstract: We aimed to investigate whether retinal and retinoic acid (RA), which are newly discovered biomarkers from our previous research, reliably predict type 2 diabetes mellitus (T2DM) development in subjects with impaired fasting glucose (IFG). Among the Korean Cancer Prevention Study (KCPS)- II cohort, subjects were selected and matched by age and sex (IFG-IFG group, n = 100 vs. IFG-DM group, n = 100) for study 1. For real-world validation of two biomarkers (study 2), other participants in the KCPS-II cohort who had IFG at baseline (n = 500) were selected.
    [Show full text]
  • Vitamin a Derivatives As Treatment Options for Retinal Degenerative Diseases
    Nutrients 2013, 5, 2646-2666; doi:10.3390/nu5072646 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Vitamin A Derivatives as Treatment Options for Retinal Degenerative Diseases Lindsay Perusek and Tadao Maeda * Department of Ophthalmology & Visual Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-4965, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-216-368-6103; Fax: +1-216-368-3171. Received: 7 May 2013; in revised form: 5 June 2013 / Accepted: 13 June 2013 / Published: 12 July 2013 Abstract: The visual cycle is a sequential enzymatic reaction for vitamin A, all-trans-retinol, occurring in the outer layer of the human retina and is essential for the maintenance of vision. The central source of retinol is derived from dietary intake of both retinol and pro-vitamin A carotenoids. A series of enzymatic reactions, located in both the photoreceptor outer segment and the retinal pigment epithelium, transform retinol into the visual chromophore 11-cis-retinal, regenerating visual pigments. Retina specific proteins carry out the majority of the visual cycle, and any significant interruption in this sequence of reactions is capable of causing varying degrees of blindness. Among these important proteins are Lecithin:retinol acyltransferase (LRAT) and retinal pigment epithelium-specific 65-kDa protein (RPE65) known to be responsible for esterification of retinol to all-trans-retinyl esters and isomerization of these esters to 11-cis-retinal, respectively. Deleterious mutations in these genes are identified in human retinal diseases that cause blindness, such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP).
    [Show full text]
  • Antioxidants and Retinal Diseases
    antioxidants Editorial Antioxidants and Retinal Diseases María Miranda 1,* and Francisco Javier Romero 2,3 1 Departamento Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, CEU Universities, 46315 Valencia, Spain 2 Facultad de Ciencias de la Salud, Universidad Europea de Valencia, 46010 Valencia, Spain; [email protected] 3 Hospital General de Requena, Generalitat Valenciana, 46340 Valencia, Spain * Correspondence: [email protected] Received: 26 November 2019; Accepted: 27 November 2019; Published: 29 November 2019 The retina is a thin membrane derived from the neuroectoderm, it is the physical morphological substrate in which the transformation of light energy into electrical impulses, that later will be led to the cerebral cortex, is performed. Due to its prosencephalic embryological origin, the retina is normally considered a specially differentiated part of the brain. It is a very complex tissue, formed by multiple cell layers and by several types of neuronal cells (ganglion, bipolar, horizontal, amacrine, and photoreceptor cells), microglia (macrophages), macroglia (Müller cells, astrocytes), and vascular cells (endothelium and pericytes). Under physiological conditions, the retina is characterized by a high oxygen consumption rate, intense exposition to pro-oxidizing agents (i.e., light) and a high content of polyunsaturated fatty acids (especially in the photoreceptor membranes). Therefore, retina is especially susceptible to oxidative stress [1–3]. Oxidative stress is defined as the imbalance between the generation and elimination of reactive oxygen species (ROS) and it results from either excessive ROS or an impaired antioxidant system. To cope with ROS increase, the retina has evolved different antioxidants defenses such as vitamin E, ascorbate, catalase, glutathione (GSH), glutathione-peroxidase, and glutathione-transferases [3].
    [Show full text]
  • Impaired Retinal Function and Vitamin a Availability in Mice Lacking Retinol-Binding Protein
    The EMBO Journal Vol.18 No.17 pp.4633–4644, 1999 Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein Loredana Quadro1,2, William S.Blaner3, (Morris-Kay and Sokolova, 1996; Napoli, 1996). With the Daniel J.Salchow4, Silke Vogel3, exception of vision, the all-trans- and 9-cis-isomers of Roseann Piantedosi3, Peter Gouras4, retinoic acid are the active retinoid forms needed to Sarah Freeman4, Maria P.Cosma2, support retinoid-dependent processes. Retinoic acid Vittorio Colantuoni2,5,6 and isomers regulate gene expression by binding to specific Max E.Gottesman1,6 nuclear receptors, the retinoic acid receptors (RARs) and retinoid X receptors (RXRs), that function as ligand- 1Institute of Cancer Research, 3Department of Medicine and dependent transcription factors (Chen and Evans, 1995; 4Department of Ophthalmology, Columbia University, College of Kurokawa et al., 1995; Leblanc and Stunnenberg, 1995; Physicians and Surgeons, New York, NY 10032, USA and Mangelsdorf et al., 1995; Pfahl and Chytil, 1996). Expres- 2Department of Biochemistry and Medical Biotechnologies, University of Naples, Via Pansini 5, 80131 Naples, Italy sion of .300 genes is influenced by retinoic acid availability (Gudas et al., 1994; Clagett-Dame and Plum, 1997). The 5Present address: Faculty of Biological Sciences, University of Sannio, 82100 Benevento, Italy retinoid used in the visual cycle is 11-cis-retinal (Wald, 1968), which forms a Schiff’s base with opsin in photo- 6Corresponding authors e-mail: [email protected] or [email protected] receptors to generate rhodopsin, the visual pigment. When excited by light, 11-cis-retinal isomerizes to all-trans- Retinol-binding protein (RBP) is the sole specific trans- retinal.
    [Show full text]
  • Key Enzymes of the Retinoid (Visual) Cycle in Vertebrate Retina☆
    Biochimica et Biophysica Acta 1821 (2012) 137–151 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbalip Review Key enzymes of the retinoid (visual) cycle in vertebrate retina☆ Philip D. Kiser a,1, Marcin Golczak a,1, Akiko Maeda a,b,⁎, Krzysztof Palczewski a,⁎⁎ a Department of Pharmacology, Case Western Reserve University, Cleveland, OH, 44106-4965, USA b Department of Ophthalmology and Vision Sciences, Case Western Reserve University, Cleveland, OH, 44106-4965, USA article info abstract Article history: A major goal in vision research over the past few decades has been to understand the molecular details of Received 19 January 2011 retinoid processing within the retinoid (visual) cycle. This includes the consequences of side reactions that Received in revised form 8 March 2011 result from delayed all-trans-retinal clearance and condensation with phospholipids that characterize a Accepted 22 March 2011 variety of serious retinal diseases. Knowledge of the basic retinoid biochemistry involved in these diseases is Available online 5 April 2011 essential for development of effective therapeutics. Photoisomerization of the 11-cis-retinal chromophore of rhodopsin triggers a complex set of metabolic transformations collectively termed phototransduction that Keywords: RPE65 ultimately lead to light perception. Continuity of vision depends on continuous conversion of all-trans-retinal Retinol dehydrogenase back to the 11-cis-retinal isomer. This process takes place in a series of reactions known as the retinoid cycle, Visual cycle which occur in photoreceptor and RPE cells. All-trans-retinal, the initial substrate of this cycle, is a chemically Retinoid cycle reactive aldehyde that can form toxic conjugates with proteins and lipids.
    [Show full text]
  • Tsin-CV; Updated 6/94
    Updated June, 2019 Andrew Tsin CURRICULUM VITAE Andrew Tsin, Ph.D. Professor and Chair Deaprtment of Molecular Science And Senior Associate Dean of Research School of Medicine The University of Texas Rio Grande Valley (UT Health – Rio Grande Valley) CONTACT INFO: Department of Molecular Science, School of Medicine The University of Texas Rio Grande Valley 1210 W. Schunior St., Edinburg, TX 78541 Phone: (956) 665-6599 Email: [email protected] CITIZENSHIP: USA and CANADA EDUCATION/TRAINING: 1973 BS in Biology, Dalhousie University, Halifax, Nova Scotia, Canada 1976 MS in Zoology (Physiology), The University of Alberta, Edmonton, Alberta, Canada 1979 Ph.D. in Zoology (Physiology), The University of Alberta, Edmonton, Alberta, Canada 1979-81 Postdoctoral Fellow, Cullen Eye Institute, Department of Ophthalmology, Program in Neuroscience, Baylor College of Medicine, Texas Medical Center, Houston, Texas CONTINUED EDUCTION: 2014 Healing Health Care Disparities through Education: An Interdisciplinary Faculty Development Program, Harvard Medical School, Boston, Massachusetts. 2016 Effective Validation of Commercialization Strategy through tactical collection and analysis of data from direct interaction with customer- a short course by The Southwest Node of the National Science Foundation Innovation Corps (I-Corps) Program, The IC2 Institute of the University of Texas at Austin. 2017 Organizational Leadership in Academic Medicine: An Executive Development Seminar for Associate Deans and Department Chairs, AAMC (Association of American Medical
    [Show full text]
  • ANNUAL REPORT 2014–2015 Stein Eye Institute ANNUAL REPORT
    ANNUAL REPORT 2014–2015 Stein Eye Institute ANNUAL REPORT July 1, 2014–June 30, 2015 Director Bartly J. Mondino, MD Faculty Advisor Debora B. Farber, PhD, DPhhc Managing Editor Tina-Marie Gauthier c/o Stein Eye Institute 100 Stein Plaza, UCLA Los Angeles, California 90095–7000 Email: [email protected] Editors Teresa Closson Susan Ito Rosalie Licht Peter J. López Ellen Pascual Debbie Sato M. Gail Summer Guest Writer Dan Gordon Photography Reed Hutchinson J. Charles Martin Robin Weisz Design Robin Weisz/Graphic Design Printing Colornet Press Send questions, comments, and updates to: [email protected]. To view the Annual Report online, visit: jsei.org/annual_report.htm. For more information about the Institute, see: www.jsei.org. ©2015 by the Regents of the University of California. All rights reserved. On the cover: Signature eyewear worn by philanthropists Edie and Lew Wasserman dominate the lobby of the Edie & Lew Wasserman Building, paying homage to the couple’s infinite vision and long- standing commitment to preventing blindness and restoring eyesight. A Year in Review 1 Stein Eye Institute 2 Transitions 6 Alumni News 6 Honors and Awards 8 Research 11 Education 13 Community Outreach 15 Philanthropy 17 Thank You 19 Jules and Doris Stein 24 Board of Trustees and Executive Committee 26 Faculty 29 Programs 87 Patient Care Services 88 Research and Treatment Centers 90 Clinical Laboratories 95 Training Programs 97 Appendices 101 Volunteer and Consulting Faculty 102 Residents and Fellows 104 Educational Offerings 105 Research Contracts and Grants 107 Clinical Research Studies 116 Publications of the Full-Time Faculty 123 Giving Opportunities 130 Dear Friends, The 2014–2015 academic term stands as a banner year for the Stein Eye Institute.
    [Show full text]
  • Conversion of Dietary Carotenoids and Vitamin a Into Bioactive Retinoids
    24 CONVERSION OF DIETARY CAROTENOIDS AND VITAMIN A INTO BIOACTIVE RETINOIDS Conversion of Dietary Carotenoids and Vitamin A into Bioactive Retinoids: Exploring trails blazed by Jim Olson James Allen Olson Memorial Lecture Earl H Harrison fects millions of children and women in the developing world. Ohio State University, Columbus, USA The widespread morbidity and mortality associated with the deficiency reflects the fact that the active forms of vitamin A (retinoids) are critical signaling molecules necessary in higher vertebrates for embryonic development, the regulation of gene transcription, visual transduction, immune function, and the control of metabolic processes. In spite of their importance in vertebrate development and physiology, the capability for the biosynthesis of molecules with retinoid activities is restricted to plants and microorganisms. Thus, animals, including humans, must obtain the essential vitamin A from the diet. Vitamin A ac- tivity in the diet comes from two sources: preformed vitamin A as retinyl esters in foods of animal origin, and provitamin A ca- rotenoids, such as β-carotene, α-carotene, and β-cryptoxanthin, found in plant-derived foods. Indeed, in areas of the world with vitamin A deficiency, the major source of vitamin A is dietary carotenoids. While the chemical and nutritional relationships of provita- min A carotenoids and vitamin A were appreciated by the 1930s it was in the last half of the 20th century that great advances in our understanding of metabolism, function, and public health significance of carotenoids and vitamin A led us to our current state of knowledge in these fields. While these advances were James Allen Olson the results of the efforts of many basic scientists, clinicians, and public health experts, James Allen Olson stands out as one of the giants in the fields of vitamin A and carotenoids.
    [Show full text]